{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:11:13Z","timestamp":1777486273093,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inflammatory bowel diseases (IBD), like ulcerative colitis (UC) and Crohn\u2019s disease (CD), are associated with urinary extra-intestinal manifestations, like urolithiasis and uncomplicated urinary tract infections (UTIs). The literature reviewed for this study identifies an increased association of CD and urolithiasis against the general population as well as UC. Furthermore, the rates in which urinary comorbidities manifest have not been well characterized in cross-race analyses. The purpose of this study is to establish the prevalence of common urinary extra-intestinal manifestations in CD and UC and to further determine at what rate these affect the African American and Caucasian populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>This is a retrospective cohort study using de-identified data collected from a research data base that included 6 integrated facilities associated with one tertiary healthcare center from 2012 to 2019. The electronic chart records for 3104 Caucasian and African American IBD patients were reviewed for frequency of urolithiasis and uncomplicated UTI via diagnosed ICD-10 codes. Comparison between data groups was made using multivariate regressions, t-tests, and chi square tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study included 3104 patients of which 59% were female, 38% were African American, and 43% were diagnosed with UC. Similar proportions of UC and CD diagnosed patients developed urolithiasis (6.0% vs 6.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.46), as well as uncomplicated UTIs (15.6% vs. 14.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.56). Similar proportions of African American and Caucasian patients developed urolithiasis (5.4% vs 7.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.09), but a higher proportion of African Americans developed uncomplicated UTIs (19.4% vs 12.6%, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found similar rates of urolithiasis formation in both UC and CD in this study. Furthermore, these rates were not significantly different between African American and Caucasian IBD populations. This suggests that UC patients have an elevated risk of urolithiasis formation as those patients with CD. Additionally, African Americans with IBD have a higher frequency of uncomplicated UTI as compared to their Caucasian counterparts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-021-00951-z","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T13:02:50Z","timestamp":1641301370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jake","family":"Herbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Teeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landen Shane","family":"Burstiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralfi","family":"Doka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amor","family":"Royer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna H.","family":"Owings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Hosseini-Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"3","key":"951_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/0974-7796.184879","volume":"8","author":"SR Gaspar","year":"2016","unstructured":"Gaspar SR, Mendonca T, Oliveira P, Oliveira T, Dias J, Lopes T. Urolithiasis and Crohn\u2019s disease. Urol Ann. 2016;8(3):297.","journal-title":"Urol Ann"},{"issue":"2","key":"951_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/07853890903559724","volume":"42","author":"S Larsen","year":"2010","unstructured":"Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42(2):97\u2013114.","journal-title":"Ann Med"},{"issue":"4","key":"951_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1572-0241.1998.156_b.x","volume":"93","author":"DS Pardi","year":"1998","unstructured":"Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998;93(4):504\u201314.","journal-title":"Am J Gastroenterol"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/IJNRD.S45466","volume":"6","author":"D Cury","year":"2013","unstructured":"Cury D, Moss A, Schor N. Nephrolithiasis in patients with inflammatory bowel disease in the community. Int J Nephrol Renov Dis. 2013;6:139\u201342.","journal-title":"Int J Nephrol Renov Dis"},{"issue":"4","key":"951_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.urology.2014.12.011","volume":"85","author":"BK Varda","year":"2015","unstructured":"Varda BK, McNabb-Baltar J, Sood A, Ghani KR, Kibel AS, Letendre J, et al. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency Department visits between 2006 and 2009. Urology. 2015;85(4):764\u201370.","journal-title":"Urology"},{"issue":"4","key":"951_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1155\/2002\/204614","volume":"16","author":"H Ben-Ami","year":"2002","unstructured":"Ben-Ami H, Ginesin Y, Behar DM, Fisher D, Edoute Y, Lavy A. Diagnosis and treatment of urinary tract complication in Crohn\u2019s disease: an experience over 15 years. Can J Gastroenterol. 2002;16(4):225\u20139.","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"951_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02393564","volume":"4","author":"J Kyle","year":"1980","unstructured":"Kyle J. Urinary complications of Crohn\u2019s disease. World J Surg. 1980;4(2):153\u20139.","journal-title":"World J Surg"},{"issue":"4","key":"951_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ibd.21777","volume":"18","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Pillot C, Oussalah A, Billioud V, Aissa N, Balde M, et al. Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience. Inflamm Bowel Dis. 2012;18(4):697\u2013702.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"951_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10151-017-1591-2","volume":"21","author":"N Valizadeh","year":"2017","unstructured":"Valizadeh N, Murray AC, Suradkar K, Al-Mazrou A, Kiran RP. Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn\u2019s disease patients. Tech Coloproctol. 2017;21(3):217\u201323.","journal-title":"Tech Coloproctol"},{"issue":"11","key":"951_CR10","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ajg.2014.313","volume":"109","author":"P Brassard","year":"2014","unstructured":"Brassard P, Bitton A, Suissa A, Sinyavskaya L, Patenaude V, Suissa S. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases. Am J Gastroenterol. 2014;109(11):1795\u2013802.","journal-title":"Am J Gastroenterol"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/524364","volume":"2011","author":"E Perez-Colon","year":"2011","unstructured":"Perez-Colon E, Dadlani GH, Wilmot I, Miller M. Mesalamine-induced myocarditis and coronary vasculitis in a pediatric ulcerative colitis patient: a case report. Case Reports in Pediatrics. 2011;2011:1\u20135.","journal-title":"Case Reports in Pediatrics"},{"issue":"8","key":"951_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.14309\/ajg.0000000000000311","volume":"114","author":"M Simsek","year":"2019","unstructured":"Simsek M, de Boer NKH. Mesalazine and nephrolithiasis: Leave no stone unturned. Am J Gastroenterol. 2019;114(8):1359\u201360.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"951_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti\u2013tumor necrosis factor therapy: results from the British society for rheumatology biologics register. Arthritis Rheum. 2006;54(8):2368\u201376.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"951_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.berh.2006.08.010","volume":"20","author":"A Strangfeld","year":"2006","unstructured":"Strangfeld A, Listing J. Bacterial and opportunistic infections during anti-tnf therapy. Best Pract Res Clin Rheumatol. 2006;20(6):1181\u201395.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"951_CR15","first-page":"101","volume":"5","author":"A Trinchieri","year":"2008","unstructured":"Trinchieri A. Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab. 2008;5(2):101\u20136.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"3","key":"951_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2215\/CJN.07610715","volume":"11","author":"GE Tasian","year":"2016","unstructured":"Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, et al. Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016;11(3):488\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"951_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (redcap)\u2014a metadata-driven methodology and workflow process for providing Translational Research Informatics Support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"951_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The redcap consortium: building an international community of Software Platform Partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"951_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ecco-jcc\/jjv138","volume":"10","author":"D Corica","year":"2015","unstructured":"Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2015;10(2):226\u201335.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"951_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gut.5.3.214","volume":"5","author":"Z Maratka","year":"1964","unstructured":"Maratka Z, Nedbal J. Urolithiasis as a complication of the surgical treatment of ulcerative colitis. Gut. 1964;5(3):214\u20137.","journal-title":"Gut"},{"issue":"4","key":"951_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.crohns.2011.02.011","volume":"5","author":"Y Zabana","year":"2011","unstructured":"Zabana Y, Van Domselaar M, Garcia-Planella E, Ma\u00f1osa M, San Rom\u00e1n AL, Gordillo J, et al. Perianal disease in patients with ulcerative colitis: a case\u2013control study. J Crohns Colitis. 2011;5(4):338\u201341.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"951_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/hsw\/30.3.265","volume":"30","author":"VC Copeland","year":"2005","unstructured":"Copeland VC. African Americans: disparities in health care access and utilization. Health Soc Work. 2005;30(3):265\u201370.","journal-title":"Health Soc Work"},{"key":"951_CR23","unstructured":"Griebling T, Litwin CS, Saigal CS. Chapter 6 Urinary tract infection in women. In: Litwin MS, editor. Urologic Disease in America. Interim Compendium April 2004. Washington, D.C.: US Government Publishing Office; 2004. p. 172\u20133. NIH Publication No. 04-5512"},{"issue":"3","key":"951_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/13557858.1996.9961793","volume":"1","author":"CO Airhihenbuwa","year":"1996","unstructured":"Airhihenbuwa CO, Kumanyika S, Agurs TD, Lowe A, Saunders D, Morssink CB. Cultural aspects of African American eating patterns. Ethnicity Health. 1996;1(3):245\u201360.","journal-title":"Ethnicity Health"},{"issue":"2","key":"951_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.urology.2011.09.040","volume":"79","author":"MJ Semins","year":"2012","unstructured":"Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology. 2012;79(2):266\u20139.","journal-title":"Urology"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-021-00951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-021-00951-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-021-00951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:21:17Z","timestamp":1641342077000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-021-00951-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s12894-021-00951-z","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved under University of Mississippi Medical Center (UMMC) IRB #2019-0194. All procedures performed in the study involving the human participants were in accordance with the ethical standards of the University of Mississippi Medical center and with the 1964 Helsinki declaration and its later amendments. The retrospective chart review was performed in accordance with UMMC IRB #2019-0194 protocol and does not require informed consent as patients received normal standard of care treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"No identifiable patient information is included in this publication. The retrospective chart review was performed in accordance with University of Mississippi Medical Center (UMMC) IRB #2019-0194 protocol and does not require informed consent as patients received normal standard of care treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}